The company's Dragonfly instrument uses a proprietary sample preparation method and isothermal amplification to diagnose a variety of infectious diseases.

The projects include the development of rapid diagnostic tests for tuberculosis, Strongyloides stercoralis, and malaria.

The company is developing blood tests for chronic diseases using artificial intelligence models and a database of more than 400,000 tissue samples.

The high-throughput antigen test includes all four dengue virus serotypes and returns results in about 18 minutes.

The partners will begin with work on a cortisol biosensor that can be used for stress and metabolic health testing.

The companies will use the Phase I Small Business Innovation Research (SBIR) grant to support the development of a urine-based ELISA to inform treatment decisions.